Constitutive glycogen synthase kinase-3/activity protects against chronic-adrenergic remodelling of the heart

Cardiovascular Research

Volumn 87, Issue 3, 2010, Pages 494-503

  Webb, Ian G ^a   Nishino, Yasuhiro ^a   Clark, James E ^a   Murdoch, Colin ^a   Walker, Simon J ^a   Makowski, Marcus R ^a   Botnar, Rene M ^a   Redwood, Simon R ^a   Shah, Ajay M ^a   Marber, Michael S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiac hypertrophy; GSK 3; Remodelling

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; ISOPRENALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 ALPHA; GLYCOGEN SYNTHASE KINASE 3 BETA; PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; AGE; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIOMEGALY; CHEMICALLY INDUCED; DISEASE MODEL; ENZYME ACTIVATION; ENZYMOLOGY; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HEART CONTRACTION; HEART MUSCLE; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHOSPHORYLATION; TRANSGENIC MOUSE;

ADRENERGIC BETA-AGONISTS; AGE FACTORS; ANIMALS; APOPTOSIS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FIBROSIS; GENE EXPRESSION REGULATION; GENOTYPE; GLYCOGEN SYNTHASE KINASE 3; HEART RATE; ISOPROTERENOL; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHENOTYPE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; STROKE VOLUME; VENTRICULAR FUNCTION; VENTRICULAR REMODELING;

EID: 77954804053     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq061     Document Type: Article

References (34)

1. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochon-drial permeability transition pore. J Clin Invest 2004;113:1535-1549.
2. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3- kinase-dependent pathway is cardioprotective. Circ Res 2002;90:377-379.
3. Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM et al. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 2002;99:907-912.
4. Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A et al. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 2000;151:117-130.
5. Haq S, Choukroun G, Lim H, Tymitz KM, del Monte F, Gwathmey J et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 2001;103:670-677.
6. Hirotani S, Zhai P, Tomita H, Galeotti J, Marquez JP, Gao S et al. Inhibition of glycogen synthase kinase 3beta during heart failure is protective. Circ Res 2007;101:1164-1174.
7. Meijer L, Flajolet M, Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci 2004;25:471-480.
8. Allen DL, Harrison BC, Maass A, Bell ML, Byrnes WC, Leinwand LA. Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J Appl Physiol 2001;90:1900-1908.
9. Eghbali M, Deva R, Alioua A, Minosyan TY, Ruan H, Wang Y et al. Molecular and functional signature of heart hypertrophy during pregnancy. Circ Res 2005;96:1208-1216.
10. Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B et al. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 1987;79:970-977.
11. Michael A, Haq S, Chen X, Hsich E, Cui L, Walters B et al. Glycogen synthase kinase-3 beta regulates growth, calcium homeostasis, and diastolic function in the heart. J Biol Chem 2004;279:21383-21393.
12. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B et al. Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA 2003;100:4610-4615.
13. Hardt SE, Tomita H, Katus HA, Sadoshima J. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy. Circ Res 2004;94:926-935.
14. Morisco C, Seta K, Hardt SE, Lee Y, Vatner SF, Sadoshima J. Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem 2001;276:28586-28597.
15. Brancaccio M, Guazzone S, Menini N, Sibona E, Hirsch E, De Andrea M et al. Melusin is a new muscle-specific interactor for beta(1) integrin cytoplasmic domain. J Biol Chem 1999;274:29282-29288.
16. Morisco C, Zebrowski D, Condorelli G, Tsichlis P, Vatner SF, Sadoshima J. The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem 2000;275:14466-14475.
17. Luckey SW, Mansoori J, Fair K, Antos CL, Olson EN, Leinwand LA. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Am J Physiol Heart Circ Physiol 2007;292: H838-H845.
18. Sanbe A, Gulick J, Hanks MC, Liang Q, Osinska H, Robbins J. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res 2003;92:609-616.
19. Zhai P, Gao S, Holle E, Yu X, Yatani A, Wagner T et al. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases. J Biol Chem 2007;282: 33181-33191.
20. Cook SA, Clerk A, Sugden PH. Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure? J Mol Cell Cardiol 2008;46:118-129.
21. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shapiro N, Marquez R et al. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 2005;24:1571-1583.
22. Matsuda T, Zhai P, Maejima Y, Hong C, Gao S, Tian B et al. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload. Proc Natl Acad Sci USA 2008;105:20900-20905.
23. Nishino Y, Webb IG, Davidson SM, Ahmed AI, Clark JE, Jacquet S et al. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or post-conditioning in the mouse. Circ Res 2008;103:307-314.
24. Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W, Wang T et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med 2007;13: 324-331.
25. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000;106:55-62.
26. Junqueira LC, Bignolas G,Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979;11:447-455.
27. Sugden PH, Fuller SJ, Weiss SC, Clerk A. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 2008;153:S137-S153.
28. Schuyler GT, Yarbrough LR. Changes in myosin and creatine kinase mRNA levels with cardiac hypertrophy and hypothyroidism. Basic Res Cardiol 1990;85:481-494.
29. Cook AR, Bardswell SC, Pretheshan S, Dighe K, Kanaganayagam GS, Jabr RI et al. Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: a role for ER stress? J Mol Cell Cardiol 2009;46:225-233.
30. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 2007;12:957-971.
31. Pluim BM, Zwinderman AH, van der LA, van der Wall EE. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 2000;101:336-344.
32. De Castro S, Pelliccia A, Caselli S, Di Angelantonio E, Papetti F, Cavarretta E et al. Remodelling of the left ventricle in athlete's heart: a three dimensional echocardio-graphic and magnetic resonance imaging study. Heart 2006;92:975-976.
33. Markou T, Cullingford TE, Giraldo A, Weiss SC, Alsafi A, Fuller SJ et al. Glycogen synthase kinases 3alpha and 3beta in cardiac myocytes: regulation and consequences of their inhibition. Cell Signal 2008;20:206-218.
34. Menon B, Johnson JN, Ross RS, Singh M, Singh K. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: role of beta1 integrins. J Mol Cell Cardiol 2007;42:653-661.